AI Terminal
Elanix Biotechnologies AG
Declaration of Voting Results & Voting Rights Announcements • Jul 22, 2019
136_dva_2019-07-22_7bd9c6fb-5b12-4de9-854a-ac7e704eb46e.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
News Details
Voting Rights Announcements | 22 July 2019 10:17
Elanix Biotechnologies AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Elanix Biotechnologies AG
22.07.2019 / 10:17
Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Notification of Major Holdings
1. Details of issuer
| Name: | Elanix Biotechnologies AG |
| Street: | c/o Frankfurt, Hanauer Landstrasse 291 B (BC GmbH) |
| Postal code: | 60314 |
| City: | Frankfurt am Main Germany |
| Legal Entity Identifier (LEI): | 391200SYNFFL0NPAJK90 |
2. Reason for notification
| Acquisition/disposal of shares with voting rights | |
| Acquisition/disposal of instruments | |
| Change of breakdown of voting rights | |
| X | Other reason: Termination of the voting right agreement |
3. Details of person subject to the notification obligationNatural person (first name, surname): Anthony De Buys Rossingh
Date of birth: 22 Sep 1967
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached:18 Dec 2018
6. Total positions
| % of voting rights attached to shares (total of 7.a.) |
% of voting rights through instruments (total of 7.b.1 + 7.b.2) |
Total of both in % (7.a. + 7.b.) |
Total number of voting rights pursuant to Sec. 41 WpHG | |
| New | 1.76 % | 0 % | 1.76 % | 8.080.902 |
| Previous notification | 19.35 % | 0 % | 19.35 % | / |
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
| ISIN | Absolute | In % | ||
| Direct (Sec. 33 WpHG) |
Indirect (Sec. 34 WpHG) |
Direct (Sec. 33 WpHG) |
Indirect (Sec. 34 WpHG) |
|
| DE000A0WMJQ4 | 142592 | 0 | 1.76 % | 0 % |
| Total | 142592 | 1.76 % |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
| Type of instrument | Expiration or maturity date | Exercise or conversion period | Voting rights absolute | Voting rights in % |
| % | ||||
| Total | % |
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
| Type of instrument | Expiration or maturity date | Exercise or conversion period | Cash or physical settlement | Voting rights absolute | Voting rights in % |
| % | |||||
| Total | % |
8. Information in relation to the person subject to the notification obligation
| X | Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). |
| Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name | % of voting rights (if at least 3% or more) | % of voting rights through instruments (if at least 5% or more) | Total of both (if at least 5% or more) |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
| Proportion of voting rights | Proportion of instruments | Total of both |
| % | % | % |
10. Other explanatory remarks:
Date
16 Jul 2019
22.07.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Elanix Biotechnologies AG |
| c/o Frankfurt, Hanauer Landstrasse 291 B (BC GmbH) | |
| 60314 Frankfurt am Main | |
| Germany | |
| Internet: | www.elanixbiotechnologies.com |
| End of News | DGAP News Service |